Arkolith/Insider Trading/VERA/Form 4

Fordyce Marshall

PRESIDENT AND CEO, DirectorVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Jul 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Sell(S)1K$40.78$41K197K
Jul 7, 2026Sell(S)33K$42.07$1.4M165K
Jul 7, 2026Sell(S)11K$42.86$450K154K
Jul 7, 2026Sell(S)2K$43.59$96K152K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001859453-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML